期刊文献+

Ets-1和MMP-9在胎膜早破合并绒毛膜羊膜炎中的表达及其意义 被引量:14

暂未订购
导出
摘要 目的探讨Ets-1和MMP-9在胎膜早破合并绒毛膜羊膜炎患者胎膜组织中的表达及其意义。方法收集住院分娩的产妇112例,分为足月胎膜早破组35例,未足月胎膜早破组37例,足月无临产征象择期剖宫产40例为对照组。分娩后行胎膜组织病理检查,根据病理结果分为合并绒毛膜羊膜炎及非合并绒毛膜羊膜炎,用免疫组化链霉菌抗生物素蛋白-过氧化物酶连接(SP)法检测Ets-1和MMP-9在胎膜组织中的表达。结果 (1)绒毛膜羊膜炎发生率:足月胎膜早破组为48.6%(17/35),未足月胎膜早破组为62.2%(23/37),对照组为12.5%(5/40),未足月胎膜早破组绒毛膜羊膜炎发生率明显高于足月胎膜早破组和对照组,差异有统计学意义(P<0.05);(2)胎膜早破组患者胎膜组织Ets-1和MMP-9的表达均明显高于对照组,差异有统计学意义(P<0.05),其中足月胎膜早破组和未足月胎膜早破组比较,差异无统计学意义(P>0.05);(3)在胎膜早破患者中,合并绒毛膜羊膜炎患者胎膜组织Ets-1和MMP-9的表达均高于未合并绒毛膜羊膜炎患者,差异有统计学意义(P<0.05);(4)各组胎膜组织中Ets-1和MMP-9表达水平呈正相关关系(r=0.789、0.810、0.756,P<0.05)。结论 Ets-1和MMP-9在胎膜早破合并绒毛膜羊膜炎患者胎膜组织中表达水平明显升高,Ets-1和MMP-9可能参与疾病的发生发展。
出处 《广东医学》 CAS CSCD 北大核心 2011年第24期3222-3224,共3页 Guangdong Medical Journal
  • 相关文献

参考文献8

  • 1SHIM S S,ROMERO R,HONG J S,et al.Clinical significance of intra-anmiotic inflammation in patients with preterm premature rupture of membrane[J].Am J Obstet Gynecol,2004,191(4):1339-1345.
  • 2MENON R,FORTUNATO S J.The role of matrix degrading enzymes and apoptosis in rupture of membranes[J].J Soc Gynecol Investig,2004,11(7):427-437.
  • 3TAKI M,VERSCHUEREN K,YOKOYAMA K,et al.Involvement of Ets-1 transcriptionfactor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells[J].Int J Oncol,2006,28(2):487-496.
  • 4WEISS A,GOLDMAN S,SHALEV E,et al.The matrix metalloproteinas (MMPs) in the deciduas and fetal membranes[J].Front Biosci,2007,12:649-659.
  • 5MICHAELIS S A,OKUDNCU A F,SARIOGLU N M,et al.The transcription factor Ets-l is expressed in human anmioehorionie membranes and is up-regulated in term and preterm premature rupture of membranes[J].J Perinat Med,2005,33(4):314-319.
  • 6罗欣,漆洪波.人胎膜组织中E26转录因子1的表达及其与胎膜早破的关系[J].中华妇产科杂志,2010,45(1):26-29. 被引量:4
  • 7SADOWSKY D W,ADAMS K M,GRAVETT M G,et al.Preterm labor is induced by intra-amniotic infusions of interleukin-1beta and tumor necrosis factor-alpha but not by interleukin-6 or interleukin-8 in a nonhuman primate model[J].Am J Obstet Gynecol,2006,195(6):1578-1589.
  • 8DI FERDINANDO A,PATACCHIOLA F,PERILLI M G,et al.Expression of matrix metalloproteinase-9 (MMP-9) in human mid-pregnancy amniotic fluid and risk of preterm labor[J].Clin Exp Obstet Gynecol,2010,37(3):193-196.

二级参考文献12

  • 1漆洪波,吴味辛.重视未足月胎膜早破的研究[J].中华妇产科杂志,2006,41(1):3-6. 被引量:170
  • 2游志鹏,汪昌运,周文天.E26转录因子-1、基质金属蛋白酶-1及其抑制剂在脉络膜黑色素瘤中的表达及意义[J].中华眼底病杂志,2006,22(3):174-176. 被引量:1
  • 3Weiss A, Goldman S, Shalev E. The matrix metalloproteinases (MMPs) in the decidua and fetal membranes. Front Biosci, 2007, 12:649-659.
  • 4Fortunato S J, Menon R. Screening of novel matrix metalloproteinases (MMPs) in human fetal membranes. J Assist Reprod Genet, 2002,19:483-486.
  • 5Singh S, Barrett J, Sakata K, et al. ETS proteins and MMPs: partners in invasion and metastasis. Curr Drug Targets, 2002,3 : 359-367.
  • 6Pham VN, Lawson ND, Mugford JW,et al. Combinatorial function of ETS transcription factors in the developing vasculature. Dev Biol, 2007,303:772-783.
  • 7Sato Y, Teruyama K, Nakano T, et al. Role of transcription factors in angiogenesis: Ets-I promotes angiogenesis as well as endothelial apoptosis. Ann N Y Acad Sci, 2001,947 : 117-123.
  • 8Takai N, Ueda T,- Narahara H,et al. Expression of c-Etsl protein in normal human plaeenta. Gyneeol Obstet Invest, 2006,61:15- 20.
  • 9Fujimoto J, Aoki I, Toyoki H, et al. Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers. Oncology, 2004,66:420-428.
  • 10Furlan A, Vercamer C, Desbiens X, et al. Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment. J Cell Physiol, 2008,215:782-793.

共引文献3

同被引文献105

引证文献14

二级引证文献90

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部